Felipe de Oliveira Franco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Felipe de Oliveira Franco has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Alexandre Dias Porto Chiavegatto Filho
Laboratory of Big Data and Predictive Analytics in Health (LABDAPS), School of Public Health, University of São Paulo
1 shared publication- Ariane Machado-Lima
University of São Paulo
1 shared publication Claudia Nogueira dos Anjos
Laboratory of Big Data and Predictive Analytics in Health (LABDAPS), School of Public Health, University of São Paulo
1 shared publication- Diego dos Santos Butrico
Department of Psychiatry, University of Sao Paulo's School of Medicine (FMUSP), Rua Doutor Ovídio Pires de Campos, 785 - Cerqueira César, São Paulo, 05403-010, São Paulo, Brazil
1 shared publication - Fernando Sumiya
Department of Psychiatry, University of Sao Paulo's School of Medicine (FMUSP), Rua Doutor Ovídio Pires de Campos, 785 - Cerqueira César, São Paulo, 05403-010, São Paulo, Brazil
1 shared publication - Fátima Lourdes Santos Nunes
Each - USP
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (11) , e0014833
Artificial intelligence for the diagnosis and prognosis of leprosy, leishmaniasis, and schistosomiasis: A systematic review
Background: Neglected Tropical Diseases affect over one billion individuals globally, challenging healthcare systems in endemic regions. While promising, Artificial Intelligence (AI) requires rigorous validation for clinical translation. Methodology: This systematic review of prediction-model studies evaluated AI applications for leprosy, schistosomiasis, and leishmaniasis (2015–2025). Methodological quality and reporting transparency of the included studies were appraised using the PROBAST+AI and TRIPOD+AI tools, respectively. Findings: Among 69 studies identified, 89.9% were published after 2020. The literature predominantly focused on diagnostic support (81.2%), leaving the prognosis of adverse outcomes underexplored (18.8%). Methodological fragility was widely observed: 89.9% of models exhibited a high risk of bias, primarily due to lack of external validation (82.6%) and failure to report or appropriately handle missing data (66.7%). Transparency remains a barrier, with source code unavailable in 76.8% of cases, hindering reproducibility. Conclusion: Current evidence indicates that quantitative output outpaces methodological maturity. Bridging the gap between algorithmic potential and public health impact requires prioritizing open science and robust validation.
- 5 November 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (11) , e0014833
Open AccessArtificial intelligence for the diagnosis and prognosis of leprosy, leishmaniasis, and schistosomiasis: A systematic review
Background: Neglected Tropical Diseases affect over one billion individuals globally, challenging healthcare systems in endemic regions. While promising, Artificial Intelligence (AI) requires rigorous validation for clinical translation. Methodology: This systematic review of prediction-model studies evaluated AI applications for leprosy, schistosomiasis, and leishmaniasis (2015–2025). Methodological quality and reporting transparency of the included studies were appraised using the PROBAST+AI and TRIPOD+AI tools, respectively. Findings: Among 69 studies identified, 89.9% were published after 2020. The literature predominantly focused on diagnostic support (81.2%), leaving the prognosis of adverse outcomes underexplored (18.8%). Methodological fragility was widely observed: 89.9% of models exhibited a high risk of bias, primarily due to lack of external validation (82.6%) and failure to report or appropriately handle missing data (66.7%). Transparency remains a barrier, with source code unavailable in 76.8% of cases, hindering reproducibility. Conclusion: Current evidence indicates that quantitative output outpaces methodological maturity. Bridging the gap between algorithmic potential and public health impact requires prioritizing open science and robust validation.
- 30 September 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 182, 109184
Enhancing ensemble classifiers utilizing gaze tracking data for autism spectrum disorder diagnosis
- 30 September 2024
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 182, 109184
Enhancing ensemble classifiers utilizing gaze tracking data for autism spectrum disorder diagnosis